FDA approves mitomycin intravesical solution for recurrent LG-IR-NMIBC
AI-based tool aims to optimize MRI use in prostate cancer diagnosis
PSMA-PET imaging product, Gozellix, launches on US market
Adding cetrelimab to niraparib maintenance shows benefit in aggressive variant prostate cancer
